Lv3
210 积分 2022-07-26 加入
Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen-Results of a Real-Life Study From a Middle-Income Country
1年前
已完结
Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study
1年前
已完结
T淋巴母细胞淋巴瘤的研究进展
1年前
已完结
Venetoclax penetrates in cerebrospinal fluid of an acute myeloid leukemia patient with leptomeningeal involvement
1年前
已完结
CAR T-cell therapies in China: rapid evolution and a bright future
2年前
已完结
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera) in combination with CHOP in patients with previously untreated CD20-positive diffuse large B-cell lymphoma: A randomized, single-blind, phase III clinical trial
2年前
已完结
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study
2年前
已完结
Safety and Preliminary Efficacy in Patients with Relapsed/Refractory Mantle Cell Lymphoma Receiving Lisocabtagene Maraleucel in Transcend NHL 001
2年前
已完结
皖公网安备34019202002308
